InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: ou71764 post# 2201

Monday, 10/28/2013 10:55:09 AM

Monday, October 28, 2013 10:55:09 AM

Post# of 703809
That's good work. One feels foolish not to have done that kind of research before investing heavily...

I hope that there is some change to the formulation of "Direct". The direct part is just injecting it directly into the tumor. That is not different. But the details of the stem cell training might be different, and yet they would still call it "Direct". One of the articles about direct that I read recently said that they had found that there was a narrow window in the stem cell maturation during which exposure to the tumor proteins resulted in much more effective programming (than during other times in development). I hope that finding is new. If not... then I understand your concern. I think I have seen such diversions before to try to bridge investor interest to a too distant future positive.

Two things that keep me hopeful. One is that article that I read about that special window for stem cell exposure (which I hope is new) and the other is the FDA fast-tracking. Why would the FDA allow this informal status for these clinicals in Houston, etc., if the formulae was not something exciting? These clinical are not double-blind. I think it is a big deal to allow such trials. But what do I know. I have a biophysics BA, by the skin of my teeth. I should have stuck to physics. Not so good with bio.

I'm new. My first post. I wanted the name Drknowlittle but apparently someone already has that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News